From Marshfield, Massachusetts, USA:
My now eight-year-old daughter was diagnosed with type 1 at age three. I have four other children who are part of a diabetic study and get blood drawn every year to look for autoantibodies. In her last blood test, my five-year-old daughter tested positive for two autoantibodies. My four-year-old daughter was positive for two autoantibodies a year ago and, this year, she was positive for three autoantibodies and her glucose tolerance test result was impaired. Can you tell me please what this means to you and how high their risks are of developing type 1?
In general, the more positive the antibodies and the more antibodies that are abnormal/positive, the higher the risks of autoimmune diabetes developing, also, the shorter duration from testing when this will occur. You should go back and discuss this with the study physicians since they can better give you the risks factors knowing the exact antibody titers, which antibodies are positive and which negative and what the trend has been over time. At some point, they would also likely suggest some home blood glucose monitoring especially with growth spurts, puberty changes and also illness since those are the times when it is most likely that the pancreas might stop making sufficient insulin. Some recent elegant antibody testing data from Finland confirms this information but it is consistent here in the U.S. as well as in Europe, Australia and Japan.
Last Updated: Wednesday October 12, 2011 13:39:50
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2017. Comments and Feedback.